Abstract
Neurosurgical emergencies in the Cardiothoracic Surgery Intensive Care Unit (CTICU) are primarily comprised of intracerebral hemorrhages occurring as a result of thromboembolic ischemic infarction with hemorrhage conversion, falls resulting in traumatic hemorrhages and spontaneous hemorrhagic complications, all of which are complicated by the antithrombotic medication (ATM) regimens required for implanted cardiac devices. Ischemic cerebral infarctions requiring decompressive craniotomy may also occur but are not a focus of this chapter, which will instead concentrate on hemorrhagic intracranial complications related to ventricular assist devices and valve surgery in the absence of bacterial endocarditis or mycotic aneurysms. Resumption of antithrombotic medications after intracranial hemorrhage (ICH) in the face of thrombogenic cardiac devices is an oft-encountered clinical dilemma for which little data exist, and will also be discussed.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Floyd TF, Cheung AT, Stecker MM. Postoperative neurologic assessment and management of the cardiac surgical patient. Semin Thorac Cardiovasc Surg. 2000;12:337–48.
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.
Cooper LB, DeVore AD, Michael FG. The impact of worsening heart failure in the United States. Heart Fail Clin. 2015;11:603–14.
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.
Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.
Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg. 1999;67:723–30.
Wever-Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. 2013;6:517–26.
Saeed O, Jermyn R, Kargoli F, et al. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015;8:551–6.
Saeed O, Shah A, Kargoli F, et al. Antiplatelet therapy and adverse hematologic events during heart mate II support. Circ Heart Fail. 2016;9:e002296.
Kulik A, Rubens FD, Baird D, et al. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey. J Heart Valve Dis. 2006;15:581–7.
Vaughan P, Waterworth PD. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair. J Heart Valve Dis. 2005;14:576–82.
Suri RM, Thourani VH, He X, et al. Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted? Ann Thorac Surg. 2013;95:1991–8. discussion 8–9
Schwann TA, Habib RH, Suri RM, et al. Variation in warfarin use at hospital discharge after isolated bioprosthetic mitral valve replacement: an analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Chest. 2016;150:597–605.
Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6.
Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. 2013;7:CD003464.
Cho SM, Moazami N, Frontera JA. Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: a systematic review. Neurocrit Care. 2017;27:17–25.
Pae WE, Connell JM, Boehmer JP, et al. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant. 2007;26:1–8.
Ramey WL, Basken RL, Walter CM, Khalpey Z, Lemole GM Jr, Dumont TM. Intracranial hemorrhage in patients with durable mechanical circulatory support devices: institutional review and proposed treatment algorithm. World Neurosurg. 2017;108:826–35.
Drews TN, Loebe M, Jurmann MJ, Weng Y, Wendelmuth C, Hetzer R. Outpatients on mechanical circulatory support. Ann Thorac Surg. 2003;75:780–5. discussion 5
Wilson TJ, Stetler WR Jr, Al-Holou WN, Sullivan SE, Fletcher JJ. Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg. 2013;118:1063–8.
Steffen RJ, Blackstone EH, Smedira NG, et al. Optimal timing of heart transplant after HeartMate II left ventricular assist device implantation. Ann Thorac Surg. 2017;104:1569–76.
Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
Bhat G, Kumar S, Aggarwal A, et al. Experience with noncardiac surgery in destination therapy left ventricular assist devices patients. ASAIO J. 2012;58:396–401.
Wong JK, Chen PC, Falvey J, et al. Anticoagulation reversal atrategies for left ventricular assist device patients presenting with acute intracranial hemorrhage. ASAIO J. 2016;62:552–7.
Jennings DL, Jacob M, Chopra A, Nemerovski CW, Morgan JA, Lanfear DE. Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices. ASAIO J. 2014;60:381–4.
Piper C, Hering D, Langer C, Horstkotte D. Etiology of stroke after mechanical heart valve replacement – results from a ten-year prospective study. J Heart Valve Dis. 2008;17:413–7.
Nishimura K, Koga M, Minematsu K, et al. Intracerebral hemorrhage in patients after heart valve replacement. J Neurol Sci. 2016;363:195–9.
Akhtar RP, Abid AR, Zafar H, Khan JS. Aniticoagulation in patients following prosthetic heart valve replacement. Ann Thorac Cardiovasc Surg. 2009;15:10–7.
AlKherayf F, Xu Y, Gandara E, Westwick H, Moldovan ID, Wells PS. Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: systematic review and meta-analysis. Thromb Res. 2016;144:152–7.
AlKherayf F, Xu Y, Westwick H, Moldovan ID, Wells PS. Timing of anticoagulant re-initiation following intracerebral hemorrhage in mechanical heart valves: survey of neurosurgeons and thrombosis experts. Clin Neurol Neurosurg. 2017;154:23–7.
Chandra D, Gupta A, Grover V, Kumar Gupta V. When should you restart anticoagulation in patients who suffer an intracranial bleed who also have a prosthetic valve? Interact Cardiovasc Thorac Surg. 2013;16:520–3.
Amin AG, Ng J, Hsu W, et al. Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas. Neurocrit Care. 2013;19:90–4.
Krittalak K, Sawanyawisuth K, Tiamkao S. Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage. Intern Med J. 2011;41:750–4.
Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery. 1998;42:769–73.
Gronseth GSCJ, Gloss D, Merillat S, Dittman J, Armstrong MJ, Getchius TS. Clinical practice guideline process manual. Minneapolis: American Academy of Neurology; 2017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sieg, E.P., Carter, R.A., Timmons, S.D. (2019). Neurologic Catastrophe in the CT ICU: A Neurosurgeon’s Dilemma. In: Lonchyna, V. (eds) Difficult Decisions in Cardiothoracic Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-04146-5_43
Download citation
DOI: https://doi.org/10.1007/978-3-030-04146-5_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04145-8
Online ISBN: 978-3-030-04146-5
eBook Packages: MedicineMedicine (R0)